Stanford researchers have combined two microscopy techniques to create a one-of-a-kind instrument that can show cell ...

HIV-seq identifies key differences in HIV-infected cells before and after starting antiretroviral therapy to support treatment research.

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

Scientists at Gladstone Institutes, in collaboration with a team at the San Francisco Veterans Affairs Medical Center, have developed a novel tool—named HIV-seq—for profiling the features of rare ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.

It’s crucial not to confuse viruses with bacteria, as viruses are infectious agents that can be pathogenic to the organisms ...

Share on Pinterest Despite the recent outbreak in India, health experts suggest the Nipah virus is an unlikely candidate for a global pandemic. Image credit: CharlesGibson/Getty Images Two new cases ...

Protestors on the steps of Sunshine Cathedral after a candlelight vigil and town hall to protest proposed changes to the State's AIDS Drug Assistance Program Update: The Florida Department of Health ...

Some countries are on high alert after two cases of a deadly, incurable virus were reported in India this week. India’s Health Ministry said Monday, Jan. 26, that two nurses at a private hospital near ...

About 1 in 10 people carry genetic variants that make them particularly vulnerable to the Epstein-Barr virus (EBV), a ubiquitous pathogen that is increasingly being linked to conditions like multiple ...

Officials in India have reported two cases of Nipah virus, a fatal infection, and some airports have increased passenger screening to prevent its spread beyond the country. The cases are among two ...